Evidence map›Paper›PMID 39838680›Full record

ArticleCurrent radiopharmaceuticals2025

The Estimation Value of

Nami Yeyin, Mohammad Abuqbeitah, Aysel Namazova, Mustafa Demir

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Current radiopharmaceuticals, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nami YeyinDepartment of Nuclear Medicine, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey.
Mohammad AbuqbeitahDepartment of Nuclear Medicine, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey.
Aysel NamazovaDepartment of Nuclear Medicine, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey.
Mustafa DemirDepartment of Nuclear Medicine, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey.

Funding

Istanbul University Cerrahpaşa Scientific Research Projects Unit 36374
6 · The paper itself

Abstract

aimThis study intended to compare the radiation dose estimates to target and nontarget liver compartments from MATERIALS AND

methodsDose estimation was performed for twenty-three eligible patients (13M, 10F) after

resultsThe mean tumor dose was 270 ± 111 Gy, the whole liver parenchyma dose was 26 ± 12 Gy, and the healthy injected liver dose was 55 ± 18 Gy from

conclusionIt was deduced that

Indexed as

Liver NeoplasmsRadiopharmaceuticalsTechnetium Tc 99m Aggregated AlbuminYttrium RadioisotopesAdultAgedFemaleHumansLiverMagnetic Resonance ImagingMaleMicrospheresMiddle AgedPositron-Emission TomographyRadiometryRadiotherapy DosageRadiopharmaceuticalsTechnetium Tc 99m Aggregated AlbuminYttrium-90Yttrium Radioisotopes90Y99mTc-MAAdosimetryPET/MRradioembolization.SPECT/CT

Identifiers

PMID39838680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.